Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant dna and transformed microorganisms
CA 2043953 C · Owner: Marrero, Luciano F. H. · Inventors: Collazo, Pedro, R.; De La Fuente Garcia, Jose De J.; Fernandez, Alicia P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the field of biotechnology and genetic engineering and in particular a novel nucleotide sequence which codes for a streptokinase as, well as the recombinant DNA obtained therefrom which is used for the transformation of various host organisms. The technical object which is pursued with the proposed solution is to produce the protein in commercially useful quantities by the recombinant method, with the possibility of alternatively using different hosts to obtain a high-quality streptokinase capable of being used as a thrombolytic agent in the treatment of different disorders. The present invention is based on the isolation of a new gene which codes for …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 1991 and granted June 12, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 5, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.